Clinical significance of hormonal receptor status of malignant ovarian tumors
Saved in:
| Date: | 2014 |
|---|---|
| Main Authors: | I. G. Tkalia, L. I. Vorobyova, V. S. Svintsitsky, S. V. Nespryadko, I. V. Goncharuk, N. Y. Lukyanova, V. F. Chekhun |
| Format: | Article |
| Language: | English |
| Published: |
2014
|
| Series: | Experimental Oncology |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0000294105 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
Clinical significance of hormonal receptor status of malignant ovarian tumors
by: Tkalia, I.G., et al.
Published: (2014)
by: Tkalia, I.G., et al.
Published: (2014)
Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor
by: I. G. Tkalia, et al.
Published: (2014)
by: I. G. Tkalia, et al.
Published: (2014)
Recurrence of borderline ovarian tumors
by: V. S. Svintsitskiy, et al.
Published: (2013)
by: V. S. Svintsitskiy, et al.
Published: (2013)
Recurrence of borderline ovarian tumors
by: Svintsitskiy, V.S., et al.
Published: (2013)
by: Svintsitskiy, V.S., et al.
Published: (2013)
Chemocine receptor CXCR4 expression and microvessels density in malignant tumors of the breast of patients with sings of metabolic syndrome
by: N. P. Yurchenko, et al.
Published: (2020)
by: N. P. Yurchenko, et al.
Published: (2020)
General clinical, biochemical parameters and peripheral blood hormone level in women at ovarian hyperstimulation syndrome
by: N. V. Avramenko, et al.
Published: (2018)
by: N. V. Avramenko, et al.
Published: (2018)
The antitumor efficacy of cisplatin in combination with triptorelin and exemestane therapy for an ovarian cancer ascites model in Wistar rats
by: I. G. Tkalia, et al.
Published: (2015)
by: I. G. Tkalia, et al.
Published: (2015)
Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
by: S. V. Chekhun, et al.
Published: (2014)
by: S. V. Chekhun, et al.
Published: (2014)
Cytomegaloviruses and malignant brain tumors
by: Lisyany, N.I., et al.
Published: (2023)
by: Lisyany, N.I., et al.
Published: (2023)
Quantitative analysis of SLC34A2 expression in different types of ovarian tumors
by: Shyian, M., et al.
Published: (2011)
by: Shyian, M., et al.
Published: (2011)
Receptor status of tumor as prognostic factor in patients with bilateral breast cancer
by: D. Y. Tsyhyka, et al.
Published: (2013)
by: D. Y. Tsyhyka, et al.
Published: (2013)
The Clinical Significance of Tumor MIR-122, -155, -182, and -200b Expression in Patients with Breast Cancer
by: V. F. Chekhun, et al.
Published: (2017)
by: V. F. Chekhun, et al.
Published: (2017)
Ovarian cancer: family cancer syndrome and clinical significance of testing of the mutations in BRCA1 and BRCA2?genes
by: O. V. Paliichuk, et al.
Published: (2016)
by: O. V. Paliichuk, et al.
Published: (2016)
Relationship between malignant tumor metabolism and tumor-bearing organism
by: T. N. Popovskaja, et al.
Published: (2019)
by: T. N. Popovskaja, et al.
Published: (2019)
Hormonal impact on tumor growth and progression
by: A. Reznikov
Published: (2015)
by: A. Reznikov
Published: (2015)
Vacuum cryo-thermal probe for destruction of malignant tumors
by: M. I. Gasanov, et al.
Published: (2013)
by: M. I. Gasanov, et al.
Published: (2013)
Hormonal-sensitive breast cancer: molecular-biological and clinical aspects of preoperative antitumor hormone therapy
by: O. V. Ponomareva
Published: (2018)
by: O. V. Ponomareva
Published: (2018)
The phenomenon of multi-drug resistance in the treatment of malignant tumors
by: S. V. Vtorushin, et al.
Published: (2014)
by: S. V. Vtorushin, et al.
Published: (2014)
The phenomenon of multi-drug resistance in the treatment of malignant tumors
by: Vtorushin, S.V., et al.
Published: (2014)
by: Vtorushin, S.V., et al.
Published: (2014)
Protein and carbohydrate metabolism disorders in patients with malignant tumors of the intestine
by: T. N. Popovskaja, et al.
Published: (2018)
by: T. N. Popovskaja, et al.
Published: (2018)
The peculiarities of ultra sound diagnostics of borderline ovarian tumors
by: E. S. Klimenko, et al.
Published: (2014)
by: E. S. Klimenko, et al.
Published: (2014)
Clinical hormonal characteristics and therapy of girls with endometrial hyperplasia and anemia
by: I. A. Tuchkina, et al.
Published: (2014)
by: I. A. Tuchkina, et al.
Published: (2014)
Genetic and epigenetic changes in malignant cells of tumors of urogenital organs
by: Gordiyuk, V.V.
Published: (2010)
by: Gordiyuk, V.V.
Published: (2010)
Laboratory parameters as predictors of bladder tumor malignancy grade
by: L. A. Derzhavets
Published: (2013)
by: L. A. Derzhavets
Published: (2013)
Application of Information Technology for Determination of Circulating Tumor Cells to Diagnostics of Malignant Tumor Diseases
by: Yu. Azarkhov, et al.
Published: (2020)
by: Yu. Azarkhov, et al.
Published: (2020)
Clinical features of patients with syndrome of biologically inactive growth hormone
by: N. A. Sprynchuk
Published: (2019)
by: N. A. Sprynchuk
Published: (2019)
Individual prognosis of serous ovarian cancer survival patients based on adhesion and proliferation of tumor cells
by: O. D. Ryabtseva, et al.
Published: (2014)
by: O. D. Ryabtseva, et al.
Published: (2014)
Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis
by: O. D. Ryabtseva, et al.
Published: (2013)
by: O. D. Ryabtseva, et al.
Published: (2013)
Expression of proteins of polyamine metabolism ferments in human prostate malignant tumors
by: S. V. Hohol
Published: (2019)
by: S. V. Hohol
Published: (2019)
Anti-Muller hormone detection and Doppler study of ovary blood supply in diagnosis of poor ovarian response syndrome
by: V. A. Pitko, et al.
Published: (2013)
by: V. A. Pitko, et al.
Published: (2013)
Nanohyperthermia of malignant tumors.i. lanthanum-strontium manganite magnetic fluid as potential inducer of tumor hyperthermia
by: Solopan, S., et al.
Published: (2011)
by: Solopan, S., et al.
Published: (2011)
An unusual case of a lesion of the right ventricle of the heart with a malignant tumor
by: R. M. Vitovskij, et al.
Published: (2018)
by: R. M. Vitovskij, et al.
Published: (2018)
Fluorescent Mueller-matrix polarimetry of biological tissues in differentiation of benign and malignant tumors
by: Yu. O. Ushenko, et al.
Published: (2015)
by: Yu. O. Ushenko, et al.
Published: (2015)
The role of the TNF receptors and apoptosis inducing ligands in tumor growth
by: O. H. Minchenko, et al.
Published: (2016)
by: O. H. Minchenko, et al.
Published: (2016)
Determination of individual genetic risk of malignant tumors in relatives of endometrial cancer patients
by: L. H. Buchynska, et al.
Published: (2018)
by: L. H. Buchynska, et al.
Published: (2018)
Clinical signification of the content of stem cells in brain tumors
by: N. I. Lisjanyj, et al.
Published: (2019)
by: N. I. Lisjanyj, et al.
Published: (2019)
Expression of miRNA-126, -205 and -214 in benign and malignant neoplasms of the prostate gland: possible diagnostic and prognostic significance
by: T. V. Zadvornyi, et al.
Published: (2019)
by: T. V. Zadvornyi, et al.
Published: (2019)
The primary culture of malignant glioma cells as a model for the study of anti-tumor activity of substances
by: I. M. Shuba, et al.
Published: (2019)
by: I. M. Shuba, et al.
Published: (2019)
History and clinical significance of electrocardiography: from sources to contemporaneity
by: N. A. Safargalina-Kornilova, et al.
Published: (2014)
by: N. A. Safargalina-Kornilova, et al.
Published: (2014)
Leptin and resistin levels in serum of patients with hematologic malignancies: correlation with clinical characteristic
by: Pamuk, G.E., et al.
Published: (2006)
by: Pamuk, G.E., et al.
Published: (2006)
Similar Items
-
Clinical significance of hormonal receptor status of malignant ovarian tumors
by: Tkalia, I.G., et al.
Published: (2014) -
Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor
by: I. G. Tkalia, et al.
Published: (2014) -
Recurrence of borderline ovarian tumors
by: V. S. Svintsitskiy, et al.
Published: (2013) -
Recurrence of borderline ovarian tumors
by: Svintsitskiy, V.S., et al.
Published: (2013) -
Chemocine receptor CXCR4 expression and microvessels density in malignant tumors of the breast of patients with sings of metabolic syndrome
by: N. P. Yurchenko, et al.
Published: (2020)